Company: APXIF
Filing Date: 2025-01-22
Form Type: F-4
Source: 0001213900-25-005463
Chunk: 84

Company: APx Acquisition Corp. I
Filing Date: 2025-01-22
Form: F-4
Chunk 84
---
x Board, as a director of the Company following the Closing; •the continued indemnification of APx’s current and former officers and directors and the continuation of directors’ and officers’ liability insurance after the Business Combination; •APx’s Existing Governing Documents provide that APx renounces its interest in any corporate opportunity offered to any director or officer unless such opportunity is expressly offered to such person solely in his or her capacity as a director or officer of APx and such opportunity is one APx is legally and contractually permitted to undertake and would otherwise be reasonable for APx to pursue, and to the extent the director or officer is permitted to refer that opportunity to APx without violating another legal obligation. Notwithstanding such provision, APx believes that such provision did not impact APx’s search for a business combination target; •the Initial Shareholders can earn a positive rate of return on their investment in APx, even if other shareholder of APx experience a negative rate of return in their investment in the Company; and •at the Closing, the Company, Parent, APx, the Initial Shareholders, and certain equity and other interest -holdersof Parent, prior to the Closing will enter into the Registration Rights Agreement, under which the Company will agree to register for resale certain Company Shares, Company Warrants and other equity securities of Company that are held by the parties thereto from time to time and the parties thereto will be provided with customary demand and piggyback registration rights. In addition, at any time prior to the Special Meeting, during a period when they are not then aware of any material non -publicinformation regarding APx or our securities, our initial shareholders, the Company and/or their respective affiliates may purchase shares and/or warrants from investors, or they may enter into transactions with such investors and others to provide them with incentives to acquire APx’s ordinary shares or vote their shares in 9 favor of the Business Combination Proposal. The purpose of such share purchases and other transactions would be to increase the likelihood that the proposals presented to shareholders for approval at the Special Meeting are approved or to provide additional equity financing. Any such share purchases and other transactions may thereby increase the likelihood of obtaining shareholder approval of the Business Combination. This may result in the completion of the Business Combination that may not otherwise have been possible. While the exact nature of any such incentives has not been determined as of the date of this proxy statement/prospectus, they might include, without limitation, arrangements to protect such investors or holders against potential loss in value of their